ArticleCancer research2020

Clonal ZEB1-Driven Mesenchymal Transition Promotes Targetable Oncologic Antiangiogenic Therapy Resistance.

Ankush Chandra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.